KR101852215B1 - 헤테로시클릭 화합물 및 이의 용도 - Google Patents

헤테로시클릭 화합물 및 이의 용도 Download PDF

Info

Publication number
KR101852215B1
KR101852215B1 KR1020137006113A KR20137006113A KR101852215B1 KR 101852215 B1 KR101852215 B1 KR 101852215B1 KR 1020137006113 A KR1020137006113 A KR 1020137006113A KR 20137006113 A KR20137006113 A KR 20137006113A KR 101852215 B1 KR101852215 B1 KR 101852215B1
Authority
KR
South Korea
Prior art keywords
substituted
optionally substituted
group
alkyl
unsubstituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020137006113A
Other languages
English (en)
Korean (ko)
Other versions
KR20130138738A (ko
Inventor
마사쿠니 고리
도시히로 이마에다
신지 나카무라
마사시 도요후쿠
에이지 혼다
야스토미 아사노
오사무 우지카와
미치요 모치즈키
Original Assignee
다케다 야쿠힌 고교 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다케다 야쿠힌 고교 가부시키가이샤 filed Critical 다케다 야쿠힌 고교 가부시키가이샤
Publication of KR20130138738A publication Critical patent/KR20130138738A/ko
Application granted granted Critical
Publication of KR101852215B1 publication Critical patent/KR101852215B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
KR1020137006113A 2010-08-10 2011-08-09 헤테로시클릭 화합물 및 이의 용도 Active KR101852215B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2010-179577 2010-08-10
JP2010179577 2010-08-10
PCT/JP2011/068497 WO2012020848A1 (en) 2010-08-10 2011-08-09 Heterocyclic compound and use thereof

Publications (2)

Publication Number Publication Date
KR20130138738A KR20130138738A (ko) 2013-12-19
KR101852215B1 true KR101852215B1 (ko) 2018-04-25

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020137006113A Active KR101852215B1 (ko) 2010-08-10 2011-08-09 헤테로시클릭 화합물 및 이의 용도

Country Status (39)

Country Link
US (11) US9150591B2 (cg-RX-API-DMAC7.html)
EP (1) EP2603513B1 (cg-RX-API-DMAC7.html)
JP (2) JP5788496B2 (cg-RX-API-DMAC7.html)
KR (1) KR101852215B1 (cg-RX-API-DMAC7.html)
CN (2) CN103180326B (cg-RX-API-DMAC7.html)
AR (1) AR082618A1 (cg-RX-API-DMAC7.html)
AU (1) AU2011290126B2 (cg-RX-API-DMAC7.html)
BR (1) BR112013002250B1 (cg-RX-API-DMAC7.html)
CA (1) CA2807460C (cg-RX-API-DMAC7.html)
CL (1) CL2013000380A1 (cg-RX-API-DMAC7.html)
CO (1) CO6680700A2 (cg-RX-API-DMAC7.html)
CR (1) CR20130066A (cg-RX-API-DMAC7.html)
CY (1) CY1123507T1 (cg-RX-API-DMAC7.html)
DK (1) DK2603513T3 (cg-RX-API-DMAC7.html)
DO (1) DOP2013000030A (cg-RX-API-DMAC7.html)
EA (1) EA022078B1 (cg-RX-API-DMAC7.html)
EC (1) ECSP13012478A (cg-RX-API-DMAC7.html)
ES (1) ES2793723T3 (cg-RX-API-DMAC7.html)
GE (1) GEP20156216B (cg-RX-API-DMAC7.html)
HR (1) HRP20200844T1 (cg-RX-API-DMAC7.html)
HU (1) HUE049460T2 (cg-RX-API-DMAC7.html)
IL (1) IL224452A (cg-RX-API-DMAC7.html)
LT (1) LT2603513T (cg-RX-API-DMAC7.html)
MA (1) MA34509B1 (cg-RX-API-DMAC7.html)
MX (1) MX349470B (cg-RX-API-DMAC7.html)
MY (1) MY165908A (cg-RX-API-DMAC7.html)
NZ (1) NZ607593A (cg-RX-API-DMAC7.html)
PE (1) PE20131116A1 (cg-RX-API-DMAC7.html)
PH (1) PH12013500247A1 (cg-RX-API-DMAC7.html)
PL (1) PL2603513T3 (cg-RX-API-DMAC7.html)
PT (1) PT2603513T (cg-RX-API-DMAC7.html)
RS (1) RS60311B1 (cg-RX-API-DMAC7.html)
SG (1) SG187656A1 (cg-RX-API-DMAC7.html)
SI (1) SI2603513T1 (cg-RX-API-DMAC7.html)
TW (1) TWI504604B (cg-RX-API-DMAC7.html)
UA (1) UA111594C2 (cg-RX-API-DMAC7.html)
UY (1) UY33551A (cg-RX-API-DMAC7.html)
WO (1) WO2012020848A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201301120B (cg-RX-API-DMAC7.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20200844T1 (hr) * 2010-08-10 2020-08-21 Takeda Pharmaceutical Company Limited Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora ampa-receptora
WO2012137982A2 (en) 2011-04-05 2012-10-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
WO2013118845A1 (ja) * 2012-02-08 2013-08-15 武田薬品工業株式会社 複素環化合物およびその用途
US20150011554A1 (en) * 2013-06-13 2015-01-08 Veroscience Llc Compositions and Methods for Treating Metabolic Disorders
EA028637B1 (ru) 2013-06-27 2017-12-29 Пфайзер Инк. Гетероароматические соединения и их применение в качестве лигандов к дофаминовым d1-рецепторам
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
HUE049827T2 (hu) 2013-12-03 2020-10-28 Fmc Corp Pirrolidinonok mint herbicidek
KR102479858B1 (ko) 2014-07-02 2022-12-21 에프엠씨 코포레이션 피페리디논계 제초제
CN107001260B (zh) 2014-12-08 2020-11-10 Fmc公司 3-氧基-3-(芳氨基)丙酸酯、其制备方法、以及其在制备吡咯烷酮中的用途
US10405547B2 (en) 2015-04-10 2019-09-10 Fmc Corporation Substituted cyclic amides as herbicides
US10582709B2 (en) 2015-04-27 2020-03-10 Fmc Corporation Butyrolactones as herbicides
WO2016176457A1 (en) * 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Imidazopyrazines and pyrazolopyrimidines and their use as ampa receptor modulators
UA120304C2 (uk) * 2015-04-29 2019-11-11 Янссен Фармацевтика Нв Азабензімідазоли та їх використання як модуляторів рецепторів ampa
WO2016182780A1 (en) 2015-05-12 2016-11-17 E I Du Pont De Nemours And Company Aryl substituted bicyclic compounds as herbicides
EP3303287B1 (en) 2015-05-29 2020-12-16 FMC Corporation Substituted cyclic amides as herbicides
CN107709310B (zh) 2015-06-02 2021-09-24 Fmc公司 取代的环酰胺及其作为除草剂的用途
BR112018001964B1 (pt) 2015-07-31 2022-05-10 Fmc Corporation Composto, composição herbicida, mistura herbicida e método para o controle docrescimento de vegetação indesejada
EP3331892B1 (en) * 2015-08-06 2019-07-03 F.Hoffmann-La Roche Ag Processes for the preparation of galnac acid derivatives
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
CN110312712B (zh) 2016-12-21 2023-06-23 Fmc公司 硝酮除草剂
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用，药物组合物
JP7201609B2 (ja) 2017-03-21 2023-01-10 エフ エム シー コーポレーション ピロリジノン及びこれらを調製するためのプロセス
MX2019011090A (es) 2017-03-21 2019-11-18 Fmc Corp Mezcla herbicida, composición y método.
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
EP3693360B1 (en) * 2017-10-06 2023-12-13 Takeda Pharmaceutical Company Limited Heterocyclic compounds
EP3693368B1 (en) * 2017-10-06 2023-12-06 Takeda Pharmaceutical Company Limited Heterocyclic compound
PL4031552T3 (pl) 2019-09-16 2025-03-17 Takeda Pharmaceutical Company Limited Pochodne azolowo-skondensowanych pirydazyn-3(2h)-onów
JP2023526249A (ja) * 2020-05-15 2023-06-21 武田薬品工業株式会社 うつ病の処置
CN113943294A (zh) * 2020-07-15 2022-01-18 成都海博为药业有限公司 一种作为btk抑制剂的化合物及其制备方法与用途
WO2025224508A1 (en) 2024-04-22 2025-10-30 Takeda Pharmaceutical Company Limited Pharmaceutical composition for treating depressive disorders

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (cg-RX-API-DMAC7.html) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) * 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) * 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
WO2001032013A1 (en) 1999-11-04 2001-05-10 Colorado State University Research Foundation Method and device for attracting insects
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MXPA04003297A (es) * 2001-10-10 2004-07-23 Neurosearch As Derivados novedosos de benzotiacina su preparacion y uso.
FR2833955B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) * 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA2655376A1 (en) 2006-06-23 2007-12-27 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
EP2102153A1 (en) * 2006-12-11 2009-09-23 Eli Lilly & Company Ampa receptor potentiators
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
WO2009061699A1 (en) 2007-11-05 2009-05-14 Schering Corporation Gamma secretase modulators
CA2709784A1 (en) 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
US20110118236A1 (en) 2008-03-25 2011-05-19 Michiyo Mochizuki Heterocyclic compound
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
EP2356115A1 (en) 2008-11-06 2011-08-17 Schering Corporation Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
JPWO2011007756A1 (ja) 2009-07-13 2012-12-27 武田薬品工業株式会社 複素環化合物及びその用途
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
HRP20200844T1 (hr) * 2010-08-10 2020-08-21 Takeda Pharmaceutical Company Limited Heterociklički spoj i njegova uporaba kao pozitivnog alosteričnog modulatora ampa-receptora

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法

Also Published As

Publication number Publication date
US20150353578A1 (en) 2015-12-10
NZ607593A (en) 2015-01-30
US20170022222A1 (en) 2017-01-26
MY165908A (en) 2018-05-18
WO2012020848A1 (en) 2012-02-16
BR112013002250A2 (pt) 2016-05-24
GEP20156216B (en) 2015-01-12
TW201217386A (en) 2012-05-01
EP2603513B1 (en) 2020-03-11
MA34509B1 (fr) 2013-09-02
AU2011290126A1 (en) 2013-03-07
MX2013001614A (es) 2013-07-05
HUE049460T2 (hu) 2020-09-28
US20190263832A1 (en) 2019-08-29
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
CN103180326A (zh) 2013-06-26
DK2603513T3 (da) 2020-06-15
US8575154B2 (en) 2013-11-05
US20130184266A1 (en) 2013-07-18
PT2603513T (pt) 2020-06-08
US20240360156A1 (en) 2024-10-31
CN104926837A (zh) 2015-09-23
US20130190291A1 (en) 2013-07-25
CR20130066A (es) 2013-05-03
CA2807460C (en) 2018-09-18
US8778934B2 (en) 2014-07-15
ES2793723T3 (es) 2020-11-16
HRP20200844T1 (hr) 2020-08-21
US11279713B2 (en) 2022-03-22
US20150073137A1 (en) 2015-03-12
PE20131116A1 (es) 2013-10-24
SG187656A1 (en) 2013-03-28
TWI504604B (zh) 2015-10-21
US9499568B2 (en) 2016-11-22
PL2603513T3 (pl) 2020-07-27
CL2013000380A1 (es) 2013-05-31
PH12013500247A1 (en) 2013-03-11
ECSP13012478A (es) 2013-04-30
US9884875B2 (en) 2018-02-06
RS60311B1 (sr) 2020-07-31
KR20130138738A (ko) 2013-12-19
JP5788496B2 (ja) 2015-09-30
CY1123507T1 (el) 2022-03-24
US20180162875A1 (en) 2018-06-14
CO6680700A2 (es) 2013-05-31
US20200317692A1 (en) 2020-10-08
DOP2013000030A (es) 2013-03-15
EA201390222A1 (ru) 2013-08-30
EA022078B1 (ru) 2015-10-30
JP2016006080A (ja) 2016-01-14
US20120077799A1 (en) 2012-03-29
LT2603513T (lt) 2020-05-25
AR082618A1 (es) 2012-12-19
JP6113789B2 (ja) 2017-04-12
BR112013002250B1 (pt) 2020-10-27
ZA201301120B (en) 2014-04-30
MX349470B (es) 2017-07-31
CA2807460A1 (en) 2012-02-16
AU2011290126B2 (en) 2016-01-07
WO2012020848A8 (en) 2012-09-27
UY33551A (es) 2012-03-30
IL224452A (en) 2017-11-30
US20140080817A1 (en) 2014-03-20
EP2603513A1 (en) 2013-06-19
JP2013535408A (ja) 2013-09-12
US8916551B2 (en) 2014-12-23
US10654874B2 (en) 2020-05-19
CN103180326B (zh) 2015-06-10
US9150591B2 (en) 2015-10-06

Similar Documents

Publication Publication Date Title
KR101852215B1 (ko) 헤테로시클릭 화합물 및 이의 용도
WO2011036889A1 (ja) 複素環化合物
JP6134654B2 (ja) 複素環化合物およびその用途
HK1182701A (en) Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator
HK1182701B (en) Heterocyclic compound and use thereof as ampa receptor positive allosteric modulator

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

R18 Changes to party contact information recorded

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R18-OTH-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000